WallStreetZenWallStreetZen

NYSE: BSX
Boston Scientific Corp Earnings & Revenue

BSX past earnings growth

How has BSX's earnings growth performed historically?
Company
140%
Industry
88.19%
Market
104.85%
BSX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BSX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BSX's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BSX past revenue growth

How has BSX's revenue growth performed historically?
Company
12.29%
Industry
9.25%
Market
17.15%
BSX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BSX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BSX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BSX earnings and revenue history

Current Revenue
$14.2B
Current Earnings
$1.6B
Current Profit Margin
11%

BSX Return on Equity

Current Company
8.5%
Current Industry
10.5%
Current Market
188%
BSX's Return on Equity (8.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BSX announces earnings.

BSX Return on Assets

Current Company
4.6%
Current Industry
5.3%
BSX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BSX Return on Capital Employed

Current Company
7.45%
Current Industry
8.3%
BSX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BSX vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BSX$14.24B$3.45B$1.57B+7.71%-2.25%
MDT$32.32B$8.88B$4.20B+1.13%-2.90%
SYK$20.50B$4.07B$3.17B+8.55%-2.57%
EW$6.00B$1.79B$1.40B+10.03%+14.97%
DXCM$3.62B$916.70M$541.50M+28.56%+49.80%

BSX earnings dates

Next earnings date
Apr 24, 2024

Boston Scientific Earnings & Revenue FAQ

What were BSX's earnings last quarter?

On Invalid Date, Boston Scientific (NYSE: BSX) reported Q4 2023 earnings per share (EPS) of $0.34, up 277.78% year over year. Total Boston Scientific earnings for the quarter were $505.00 million. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.09.

If you're new to stock investing, here's how to buy Boston Scientific stock.

What was BSX's earnings growth in the past year?

As of Q2 2024, Boston Scientific's earnings has grown 140% year over year. This is 51.81 percentage points higher than the US Medical Devices industry earnings growth rate of 88.19%. Boston Scientific's earnings in the past year totalled $1.57 billion.

What is BSX's earnings date?

Boston Scientific's earnings date is Invalid Date. Add BSX to your watchlist to be reminded of BSX's next earnings announcement.

What was BSX's revenue last quarter?

On Invalid Date, Boston Scientific (NYSE: BSX) reported Q4 2023 revenue of $3.73 billion up 14.9% year over year. In the same quarter last year, Boston Scientific's revenue was $3.24 billion.

What was BSX's revenue growth in the past year?

As of Q2 2024, Boston Scientific's revenue has grown 12.29% year over year. This is 3.03 percentage points higher than the US Medical Devices industry revenue growth rate of 9.25%. Boston Scientific's revenue in the past year totalled $14.24 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.